Status:
RECRUITING
Clinical Outcomes of Patients Undergoing CABG Surgery With VEST Supported Venous Grafts
Lead Sponsor:
Cardiocentro Ticino
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18+ years
Brief Summary
This is a prospective, investigator-initiated, multi-center, open label and post-market registry, enrolling patients with atherosclerotic coronary artery disease, scheduled for CABG with at least one ...
Eligibility Criteria
Inclusion
- Patient scheduled for planned CABG procedure with at least one SVG bypass with pre-planned VEST treatment.
- Saphenous vein graft length and diameter are adequate for the planned intervention.
- Patient is willing and able to give their written informed consent to participate in the registry study.
- Patient is over 18 years of age
Exclusion
- Emergency CABG surgery (cardiogenic shock, inotropic pressure support, IABP)
- Participating in any other investigational study for either drug or device which can influence collection of valid data under this study
Key Trial Info
Start Date :
December 15 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 30 2026
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04761068
Start Date
December 15 2017
End Date
March 30 2026
Last Update
February 18 2021
Active Locations (13)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Innsbruck
Innsbruck, Austria
2
AKH (Vienna General Hospital)
Vienna, Austria
3
Floridsdorf Clinic
Vienna, Austria
4
Herzzentrum Dresden
Dresden, Germany